Eurocrit Labs International Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 29-11-2024
- Paid Up Capital ₹ 5.00 Cr
as on 29-11-2024
- Company Age 3 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 24.55 Cr
as on 29-11-2024
- Revenue %
(FY 2023)
- Net Worth 49900.00%
(FY 2023)
- Total Assets 1206.48%
(FY 2023)
About Eurocrit Labs International
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹24.55 Cr.
Nikhil Khubchandani and Ankuj Khanna serve as directors at the Company.
- CIN/LLPIN
U24299HR2021PTC098441
- Company No.
098441
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Oct 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Eurocrit Labs International?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikhil Khubchandani  | Director | 13-Oct-2021 | Current |
| Ankuj Khanna | Director | 13-Oct-2021 | Current |
Financial Performance of Eurocrit Labs International.
Eurocrit Labs International Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 49900%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Eurocrit Labs International?
In 2023, Eurocrit Labs International had a promoter holding of 59.00% and a public holding of 41.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Trumount Pharmaceuticals Private LimitedActive 3 years 3 months
Nikhil Khubchandani is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Jul 2024 | ₹14.70 Cr | Open |
Others Creation Date: 28 Feb 2023 | ₹9.85 Cr | Open |
How Many Employees Work at Eurocrit Labs International?
Unlock and access historical data on people associated with Eurocrit Labs International, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eurocrit Labs International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eurocrit Labs International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
